SCHEMBL3847422

SCHEMBL3847422

CN1CCN(c2ccnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4-c4ccc(F)cc4)cc23)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 4/20 0.42
ALDH1A1 P00352 6/20 0.40
CYP1A2 P05177 5/20 0.40
CYP3A4 P08684 5/20 0.40
TSHR P16473 4/20 0.40
HIF1A Q16665 4/20 0.40
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
CYP2D6 P10635 3/20 0.40
CYP2C19 P33261 3/20 0.40
USP2 O75604 3/20 0.40
MAPK1 P28482 3/20 0.40
PIK3CA P42336 3/20 0.39
LMNA P02545 3/20 0.38
KDM4E B2RXH2 3/20 0.38
HPGD P15428 3/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SCN9A Q15858 1/20 0.38
CLK4 Q9HAZ1 2/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3850522 0.89 CYP1A2 (0.42) MAPKAPK2ALDH1A1CYP1A2CYP3A4TSHR
SCHEMBL3847996 0.88 CHRM4 (0.43) PIK3CA
SCHEMBL3848852 0.86 ALDH1A1 (0.43) MAPKAPK2ALDH1A1CYP1A2CYP3A4TSHR
SCHEMBL3846231 0.86 MAPKAPK2 (0.46) MAPKAPK2ALDH1A1CYP1A2CYP3A4TSHR
SCHEMBL3847140 0.85 CSNK1D (0.35) ALDH1A1CYP1A2CYP3A4TSHRHIF1A
SCHEMBL3847626 0.81 CSNK1D (0.39) PIK3CAACVR1CSNK1DCSNK1E
SCHEMBL3852071 0.79 MAPK14 (0.36) PIK3CAACVR1CSNK1DCSNK1E
SCHEMBL3846521 0.79 MAPKAPK2 (0.46) MAPKAPK2ALDH1A1CYP1A2CYP3A4MEN1
SCHEMBL3847727 0.78 PIK3CD (0.41) ALDH1A1CYP1A2CYP3A4TSHRHIF1A
Hydrochloric Acid SCHEMBL3845212 0.77 MAPKAPK2 (0.47) MAPKAPK2ALDH1A1CYP1A2CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed